(1R,6R,8R,10R,17R,19S)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-4,13-dihydroxy-4,13-dioxo-3,5,9,12,15,18-hexaoxa-4λ5,13λ5-diphosphatricyclo[14.2.1.06,10]nonadecane-7,19-diol

C22H27N9O12P2 — CID 157145181

IUPAC(1R,6R,8R,10R,17R,19S)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-4,13-dihydroxy-4,13-dioxo-3,5,9,12,15,18-hexaoxa-4λ5,13λ5-diphosphatricyclo[14.2.1.06,10]nonadecane-7,19-diol
SMILESNc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@@H]3C(O)[C@H](n4cnc5c(N)ccnc54)O[C@@H]3COP(=O)(O)COC1[C@H]2O
InChIInChI=1S/C22H27N9O12P2/c23-9-1-2-25-19-12(9)28-6-30(19)21-15(33)16-11(42-21)4-39-44(34,35)8-38-17-14(32)10(3-40-45(36,37)43-16)41-22(17)31-7-29-13-18(24)26-5-27-20(13)31/h1-2,5-7,10-11,14-17,21-22,32-33H,3-4,8H2,(H2,23,25)(H,34,35)(H,36,37)(H2,24,26,27)/t10-,11-,14+,15?,16+,17?,21-,22-/m1/s1
InChIKeyYXWJNOVOYLLVCS-WKJVLIDGSA-N
MW671.46 g/mol
LogP-0.99
Rot. Bonds2

About (1R,6R,8R,10R,17R,19S)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-4,13-dihydroxy-4,13-dioxo-3,5,9,12,15,18-hexaoxa-4λ5,13λ5-diphosphatricyclo[14.2.1.06,10]nonadecane-7,19-diol

(1R,6R,8R,10R,17R,19S)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-4,13-dihydroxy-4,13-dioxo-3,5,9,12,15,18-hexaoxa-4λ5,13λ5-diphosphatricyclo[14.2.1.06,10]nonadecane-7,19-diol (PubChem CID 157145181) has the molecular formula C22H27N9O12P2 and a molecular weight of 671.46 g/mol. Its IUPAC name is (1R,6R,8R,10R,17R,19S)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-4,13-dihydroxy-4,13-dioxo-3,5,9,12,15,18-hexaoxa-4λ5,13λ5-diphosphatricyclo[14.2.1.06,10]nonadecane-7,19-diol.

Molecular Properties

Compound Name(1R,6R,8R,10R,17R,19S)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-4,13-dihydroxy-4,13-dioxo-3,5,9,12,15,18-hexaoxa-4λ5,13λ5-diphosphatricyclo[14.2.1.06,10]nonadecane-7,19-diol
PubChem CID157145181
Molecular FormulaC22H27N9O12P2
Molecular Weight671.46 g/mol
Exact Mass671.13
IUPAC Name(1R,6R,8R,10R,17R,19S)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-4,13-dihydroxy-4,13-dioxo-3,5,9,12,15,18-hexaoxa-4λ5,13λ5-diphosphatricyclo[14.2.1.06,10]nonadecane-7,19-diol
SMILESNc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@@H]3C(O)[C@H](n4cnc5c(N)ccnc54)O[C@@H]3COP(=O)(O)COC1[C@H]2O
InChIInChI=1S/C22H27N9O12P2/c23-9-1-2-25-19-12(9)28-6-30(19)21-15(33)16-11(42-21)4-39-44(34,35)8-38-17-14(32)10(3-40-45(36,37)43-16)41-22(17)31-7-29-13-18(24)26-5-27-20(13)31/h1-2,5-7,10-11,14-17,21-22,32-33H,3-4,8H2,(H2,23,25)(H,34,35)(H,36,37)(H2,24,26,27)/t10-,11-,14+,15?,16+,17?,21-,22-/m1/s1
InChIKeyYXWJNOVOYLLVCS-WKJVLIDGSA-N
XLogP-0.99
TPSA296.79 Ų
H-Bond Donors6
H-Bond Acceptors19
Rotatable Bonds2
Heavy Atoms45
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500671.46
LogP ≤ 5-0.99
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze (1R,6R,8R,10R,17R,19S)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-4,13-dihydroxy-4,13-dioxo-3,5,9,12,15,18-hexaoxa-4λ5,13λ5-diphosphatricyclo[14.2.1.06,10]nonadecane-7,19-diol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,6R,8R,10R,17R,19S)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-4,13-dihydroxy-4,13-dioxo-3,5,9,12,15,18-hexaoxa-4λ5,13λ5-diphosphatricyclo[14.2.1.06,10]nonadecane-7,19-diol?
The IUPAC name of (1R,6R,8R,10R,17R,19S)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-4,13-dihydroxy-4,13-dioxo-3,5,9,12,15,18-hexaoxa-4λ5,13λ5-diphosphatricyclo[14.2.1.06,10]nonadecane-7,19-diol (CID 157145181) is (1R,6R,8R,10R,17R,19S)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-4,13-dihydroxy-4,13-dioxo-3,5,9,12,15,18-hexaoxa-4λ5,13λ5-diphosphatricyclo[14.2.1.06,10]nonadecane-7,19-diol.
What is the SMILES notation for (1R,6R,8R,10R,17R,19S)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-4,13-dihydroxy-4,13-dioxo-3,5,9,12,15,18-hexaoxa-4λ5,13λ5-diphosphatricyclo[14.2.1.06,10]nonadecane-7,19-diol?
The canonical SMILES for (1R,6R,8R,10R,17R,19S)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-4,13-dihydroxy-4,13-dioxo-3,5,9,12,15,18-hexaoxa-4λ5,13λ5-diphosphatricyclo[14.2.1.06,10]nonadecane-7,19-diol is Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@@H]3C(O)[C@H](n4cnc5c(N)ccnc54)O[C@@H]3COP(=O)(O)COC1[C@H]2O.
What is the InChIKey of (1R,6R,8R,10R,17R,19S)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-4,13-dihydroxy-4,13-dioxo-3,5,9,12,15,18-hexaoxa-4λ5,13λ5-diphosphatricyclo[14.2.1.06,10]nonadecane-7,19-diol?
The InChIKey is YXWJNOVOYLLVCS-WKJVLIDGSA-N. The full InChI is InChI=1S/C22H27N9O12P2/c23-9-1-2-25-19-12(9)28-6-30(19)21-15(33)16-11(42-21)4-39-44(34,35)8-38-17-14(32)10(3-40-45(36,37)43-16)41-22(17)31-7-29-13-18(24)26-5-27-20(13)31/h1-2,5-7,10-11,14-17,21-22,32-33H,3-4,8H2,(H2,23,25)(H,34,35)(H,36,37)(H2,24,26,27)/t10-,11-,14+,15?,16+,17?,21-,22-/m1/s1.
What are the key properties of (1R,6R,8R,10R,17R,19S)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-4,13-dihydroxy-4,13-dioxo-3,5,9,12,15,18-hexaoxa-4λ5,13λ5-diphosphatricyclo[14.2.1.06,10]nonadecane-7,19-diol?
(1R,6R,8R,10R,17R,19S)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-4,13-dihydroxy-4,13-dioxo-3,5,9,12,15,18-hexaoxa-4λ5,13λ5-diphosphatricyclo[14.2.1.06,10]nonadecane-7,19-diol has a molecular weight of 671.46 g/mol, XLogP of -0.99, 2 rotatable bonds, 6 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,6R,8R,10R,17R,19S)-8-(7-aminoimidazo[4,5-b]pyridin-3-yl)-17-(6-aminopurin-9-yl)-4,13-dihydroxy-4,13-dioxo-3,5,9,12,15,18-hexaoxa-4λ5,13λ5-diphosphatricyclo[14.2.1.06,10]nonadecane-7,19-diol is sourced from PubChem (CID 157145181), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).